Lenalidomide (Revlimid) combined with continuous oral cyclophosphamide (endoxan) and prednisone (REP) is effective in lenalidomide/dexamethasone-refractory myeloma (Q43189899)
Jump to navigation
Jump to search
scientific article published in January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lenalidomide (Revlimid) combined with continuous oral cyclophosphamide (endoxan) and prednisone (REP) is effective in lenalidomide/dexamethasone-refractory myeloma |
scientific article published in January 2010 |
Statements
1 reference
Lenalidomide (Revlimid) combined with continuous oral cyclophosphamide (endoxan) and prednisone (REP) is effective in lenalidomide/dexamethasone-refractory myeloma (English)
1 reference
Monique C Minnema
1 reference
Niels W C J van de Donk
1 reference
Henk M Lokhorst
1 reference
Shulamit Wittebol
1 reference
1 January 2010
1 reference
1 reference
Identifiers
1 reference